Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Dormans T, Buijs J, Gronenschild M, de Kruif MD, van Haren EHJ, van Kraaij T, Leers MPG, Peeters R, Wong DR, Landewé RBM. Ramiro S, et al. Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. Alunno A, et al. Ann Rheum Dis. 2021 Jun;80(6):698-706. doi: 10.1136/annrheumdis-2020-219724. Epub 2021 Feb 5. Ann Rheum Dis. 2021. PMID: 33547062 Free PMC article.
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer.
Martens RJH, van Adrichem AJ, Mattheij NJA, Brouwer CG, van Twist DJL, Broerse JJCR, Magro-Checa C, van Dongen CMP, Mostard RLM, Ramiro S, Landewé RBM, Leers MPG. Martens RJH, et al. Clin Chem Lab Med. 2020 Dec 9;59(4):783-793. doi: 10.1515/cclm-2020-1529. Print 2021 Mar 26. Clin Chem Lab Med. 2020. PMID: 33554540 Free article.
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes IB, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. Alunno A, et al. Among authors: magro checa c. Ann Rheum Dis. 2022 Jan;81(1):34-40. doi: 10.1136/annrheumdis-2021-221366. Epub 2021 Oct 7. Ann Rheum Dis. 2022. PMID: 34620584 Free article.
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER).
Magro-Checa C, Ramiro S, Rúa-Figueroa I, Jimenez N, Del Campo-Pérez V, Martinez-Barrio J, Galindo-Izquierdo M, Calvo-Alén J, Uriarte-Isacelaya E, Tomero-Muriel E, Freire-González M, Martínez-Taboada V, Salgado E, Vela P, Mena-Vázquez N, Olivé A, Narváez J, Menor-Almagro R, Santos-Soler G, Hernández-Beriaín JA, Manero-Ruiz J, Aurrecoechea-Aguinaga E, Ibarguengoitia O, Montilla-Morales C, Bonilla-Hernán G, Torrente-Segarra V, Salman-Monte T, Ros-Vilamajo I, García-Villanueva MJ, Moriano-Morales C, Fito-Manteca C, Lozano-Rivas N, Bohórquez C, Pego-Reigosa JM. Magro-Checa C, et al. Semin Arthritis Rheum. 2023 Feb;58:152121. doi: 10.1016/j.semarthrit.2022.152121. Epub 2022 Oct 22. Semin Arthritis Rheum. 2023. PMID: 36375359
57 results